Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 228,394,293 papers from all fields of science
Search
Sign In
Create Free Account
Cisplatin
Known as:
Cisplatina
, Cysplatyna
, Cis-platinum II Diamine Dichloride
Expand
An alkylating-like inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity. Cisplatin forms highly reactive, charged…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
49 relations
Broader (1)
Antineoplastic Agents
Astrocytoma
CVACE protocol
CVB protocol
Cisplatin 1 MG/ML Injectable Solution
Expand
Narrower (21)
Briplatin
CE-AVN protocol
CISCA protocol
COMPE protocol
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2000
Review
2000
Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.
K. Sultanem
,
H. Shu
,
+4 authors
K. Fu
International Journal of Radiation Oncology…
2000
Corpus ID: 40604380
Highly Cited
1996
Highly Cited
1996
Detection of DNA‐crosslinking agents with the alkaline comet assay
S. Pfuhler
,
Hans Uwe Wolf
Environmental and Molecular Mutagenesis
1996
Corpus ID: 45110896
The single cell gel electrophoresis, or comet assay, under alkaline conditions is a sensitive, simple and rapid method for the…
Expand
Highly Cited
1989
Highly Cited
1989
A new methodology for the optimal design and production schedule of multipurpose batch plants
J. Cerdá
,
M. Vicente
,
J. Gutiérrez
,
S. Esplugas
,
J. Mata
1989
Corpus ID: 97575616
Presentation d'une procedure algorithmique determinant simultanement le programme optimal de production et les tailles des…
Expand
Highly Cited
1988
Highly Cited
1988
Enhancement of the antiproliferative effect of cis‐diamminedichloroplatinum(II) and nitrogen mustard by inhibitors of protein kinase C
J. Hofmann
,
W. Doppler
,
+4 authors
H. Grunicke
International Journal of Cancer
1988
Corpus ID: 11513259
Quercetin (3, 3′, 4′, 5, 7‐pentahydroxyflavone) has been shown to inhibit a variety of enzymes including the calcium‐ and…
Expand
Highly Cited
1985
Highly Cited
1985
The asymmetric synthesis of β-lactam antibiotics - I. application of chiral oxazolidones in the staudinger reaction.
D. A. Evans
,
E. Sjogren
1985
Corpus ID: 97481854
Highly Cited
1981
Highly Cited
1981
cis-Polyunsaturated fatty acids induce high levels of superoxide production by human neutrophils.
J. Badwey
,
J. Curnutte
,
M. L. Karnovsky
Journal of Biological Chemistry
1981
Corpus ID: 12200109
Highly Cited
1979
Highly Cited
1979
Binding of cis- and trans-dichlorodiammineplatinum(II) to DNA: evidence for unwinding and shortening of the double helix.
G. L. Cohen
,
W. Bauer
,
J. Barton
,
S. Lippard
Science
1979
Corpus ID: 35187906
The antitumor drug cis-dichlorodiammineplatinum(II) (cis-DDP) and the inactive trans isomer bind and produce cooperative changes…
Expand
Highly Cited
1978
Highly Cited
1978
Platinum complexes as radiosensitizers of hypoxic mammalian cells.
E. Douple
,
R. Richmond
The British journal of cancer. Supplement
1978
Corpus ID: 2500974
Cis-dichlorodiammineplatinum (II), or cis-PDD, has recently been shown to be a potent radiosensitizer of bacteria, particularly…
Expand
Highly Cited
1977
Highly Cited
1977
Formation of singlet oxygen by the myeloperoxidase-mediated antimicrobial system.
H. Rosen
,
S. Klebanoff
Journal of Biological Chemistry
1977
Corpus ID: 30176120
Highly Cited
1977
Highly Cited
1977
Evaluation of single agents and combinations of chemotherapeutic agents in mouse colon carcinomas
Phd T. H. CORBETT
,
J. D. D. P. GRISWOLD
,
+14 authors
Albert Moody
Cancer
1977
Corpus ID: 43411643
Single agents and combinations of agents were tested for antitumor activity against four transplantable colon tumors in mice. The…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE